Immunoprecise Antibodies Ltd (IPA) — Cash Flow Reinvestment Rate
Immunoprecise Antibodies Ltd (IPA) has a Cash Flow Reinvestment Rate of 3.25x as of October 2020, reinvesting $1.43 Million (capex $715.21K plus investments $-715.21K) from operating cash flow of $440.23K. See Immunoprecise Antibodies Ltd (IPA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Immunoprecise Antibodies Ltd Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Immunoprecise Antibodies Ltd across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Immunoprecise Antibodies Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Immunoprecise Antibodies Ltd (2016–2016)
Year-by-year capital reinvestment analysis for Immunoprecise Antibodies Ltd. See Immunoprecise Antibodies Ltd (IPA) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.06x | $17.48K | $284.09K | $17.48K | — |